Alkermes plc. — Director's Dealing 2018

Feb 9, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Alkermes plc. (ALKS)
CIK: 0001520262
Period of Report: 2018-02-01

Reporting Person: Hopkinson Craig C. (SVP, Med Dev/Med Affairs, CMO)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to Buy)	$59.57	2027-06-07	Ordinary Shares (80000)		Direct
Restricted Stock Unit Award	$0		Ordinary Shares (5000)		Direct

Footnotes

F1: Shares subject to the stock option award vest in four equal annual installments commencing on 6/7/18.

F2: Shares subject to the restricted stock unit award vest in four equal annual installments commencing on 6/7/18.